Sempra signals a 20% increase in Oncor's $47.5 billion capital plan, discounting the high range of $4.80-$5.30 adjusted for the 2026 EPS range (NYSE:SRE).
Sempra signals a 20% increase in Oncor's $47.5 billion capital plan, discounting the high range of $4.80-$5.30 adjusted for the 2026 EPS range (NYSE:SRE).
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in